+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Identification of novel polo-like kinase 1 inhibitors by a hybrid virtual screening



Identification of novel polo-like kinase 1 inhibitors by a hybrid virtual screening



Chemical Biology and Drug Design 80(2): 328-339



Polo-like kinase 1 is an important and attractive oncological target that plays a key role in mitosis and cytokinesis. A combined pharmacophore- and docking-based virtual screening was performed to identify novel polo-like kinase 1 inhibitors. A total of 34 hit compounds were selected and tested in vitro, and some compounds showed inhibition of polo-like kinase 1 and human tumor cell growth. The most potent compound (66) inhibited polo-like kinase 1 with an IC(50) value of 6.99 μm. The docked binding models of two hit compounds were discussed in detail. These compounds contained novel chemical scaffolds and may be used as foundations for the development of novel classes of polo-like kinase 1 inhibitors.

(PDF emailed within 0-6 h: $19.90)

Accession: 036398730

Download citation: RISBibTeXText

PMID: 22583481

DOI: 10.1111/j.1747-0285.2012.01412.x


Related references

Identification of green tea catechins as potent inhibitors of the polo-box domain of polo-like kinase 1. Chemmedchem 10(1): 158-163, 2015

Integration of virtual screening with high-throughput screening for the identification of novel Rho-kinase I inhibitors. Journal of Biotechnology 145(3): 295-303, 2010

Pharmacophore modeling and hybrid virtual screening for the discovery of novel IκB kinase 2 (IKK2) inhibitors. Journal of Biomolecular Structure and Dynamics 29(1): 165-179, 2011

Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening. Bioorganic & Medicinal Chemistry Letters 13(21): 3693-3699, 3 November, 2003

Hybrid structure-based virtual screening protocol for the identification of novel BACE1 inhibitors. Journal of Chemical Information and Modeling 49(3): 647-657, 2009

Identification of Highly Potent Protein Kinase C-Related Kinase 1 Inhibitors by Virtual Screening, Binding Free Energy Rescoring, and in vitro Testing. Chemmedchem 11(18): 2084-2094, 2017

Identification of novel BRAF kinase inhibitors with structure-based virtual screening. Bioorganic and Medicinal Chemistry Letters 21(19): 5753-5756, 2012

Identification of Inhibitors of the Tyrosine Kinase c-Met by Structure-Based Virtual Screening. Molecular Informatics 30(2-3): 145-150, 2011

Identification of p38α MAP kinase inhibitors by pharmacophore based virtual screening. Journal of Molecular Graphics and Modelling 49: 18-24, 2014

Phosphoinositide-3-kinase (PI3K) inhibitors: identification of new scaffolds using virtual screening. Bioorganic and Medicinal Chemistry Letters 19(20): 5842-5847, 2010

NF-kappaB inducing kinase (NIK) inhibitors: identification of new scaffolds using virtual screening. Bioorganic and Medicinal Chemistry Letters 20(15): 4515-4520, 2010

Pharmacophore modelling and virtual screening for identification of new Aurora-A kinase inhibitors. Chemical Biology and Drug Design 71(6): 533-539, 2008

Structure modeling and hybrid virtual screening study of Alzheimers associated protease kallikrein 8 for the identification of novel inhibitors. Medicinal Chemistry Research 23(7): 3516-3527, 2014

Identification of potential glycogen kinase-3 inhibitors by structure based virtual screening. Biophysical Chemistry 128(2-3): 165-175, 2007

Identification of protein kinase CK2 inhibitors using solvent dipole ordering virtual screening. European Journal of Medicinal Chemistry 96: 396-404, 2016